PierianDx
PierianDx Closes Equity Financing, Loan Facility for up to $47.5M
OrbiMed was the lead investor in the new financing, which is expected to drive PierianDx's commercial expansion. The firm raised $27 million in 2019.
Belgian Society of Medical Oncology to Study Value of Genomic Profiling for Cancer Patients
The Belgian Society of Medical Oncology has partnered with Illumina, OncoDNA, and PierianDx for this study, which will enroll 864 patients with advanced metastatic cancer.
Illumina, PierianDx Expand Partnership on Cancer Panel Test Reporting
The deal builds on a non-exclusive partnership signed in January 2019 and PierianDx will now support three more Illumina cancer sequencing assays.
Oct 28, 2019
PierianDx Raises $27M in Series B Round
Mar 12, 2019
Forensic Genomics Firm Othram Raises $4M
Feb 13, 2018
PierianDx Raises $3M in New Funding, Seeks $2M More
Nov 2, 2015
Nov 2, 2015
Tute Genomics Acquires Knome
Aug 15, 2014